NMDA and opioid receptors: Their interactions in antinociception, tolerance and neuroplasticity

Brain Research Reviews

Volumn 30, Issue 3, 1999, Pages 289-304

  Mao, Jianren ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Interaction; NMDA; Opioid receptor

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ALFENTANIL; BUPIVACAINE; CALCIUM CHANNEL; DELTA OPIATE RECEPTOR; DEXTROMETHORPHAN; DYNORPHIN A; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FENTANYL; HYDROMORPHONE; IFENPRODIL; KAPPA OPIATE RECEPTOR; KETAMINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NITRIC OXIDE; NORBINALTORPHIMINE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; PROTEIN KINASE;

ALLODYNIA; ANTINOCICEPTION; DRUG DEPENDENCE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; ELECTROPHYSIOLOGY; HUMAN; HYPERALGESIA; MORPHINE TOLERANCE; MOTOR ACTIVITY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032737685     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00020-X     Document Type: Article

References (139)

1. Aley K.O., Levine J.D. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats. J. Neurosci. 17:1997;3907-3912.
2. + channels by cytoplasmic and membrane-associated C kinase. J. Neurochem. 51:1988;903-917.
3. Arvidsson U., Dado R.J., Riedl M., Lee J.H., Law P.Y., Loh H.H., Elde R., Wessendorf M.W. Delta-opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J. Neurosci. 15:1995;1215-1235.
4. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15:1995;3328-3341.
5. Arvidsson U., Riedl M., Chakrabarti S., Vulchanova L., Lee J.H., Nakano A.H., Lin X., Loh H.H., Law P.Y., Wessendorf M.W. The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5062-5066.
6. Attal N., Chen Y.L., Kayser V., Guilbaud G. Behavioral evidence that systemic morphine may modulate a phasic pain-related behavior in a rat model of peripheral mononeuropathy. Pain. 47:1991;65-70.
7. Bartlett S.E., Dodd P.R., Smith M.T. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Pharmacol. Toxicol. 75:1994;73-81.
8. Bausch S.B., Patterson T.A., Appleyard S.M., Chavkin C. Immunocytochemical localization of delta opioid receptors in mouse brain. J. Chem. Neuroanat. 8:1995;175-189.
9. Ben Eliyahu S., Marek P., Vaccarino A.L., Mogil J.S., Sternberg W.F., Liebeskind J.C. The NMDA receptor antagonist, MK-801, prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:1992;304-308.
10. G.J. Bennett, K.C. Kajander, Y. Sahara, M.J. Iadarola, T. Sugimoto, Neurochemical and anatomical changes in the dorsal horn of rats with an experimental painful peripheral neuropathy, in: F. Cervero, G.J. Bennett, P.M. Headley (Eds.), Proceedings of Sensory Information in the Superficial Dorsal Horn of the Spinal Cord, Plenum, New York, 1989, pp. 463-471.
11. Bernardi M., Bertolini A., Szczawinska K., Genedani S. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice. Eur. J. Pharmacol. 298:1996;51-55.
12. Bespalov A.Y., Zvartau E.E. Intra-accumbens administration of NMDA receptor antagonist (±)CPP prevents locomotor activation conditioned by morphine and amphetamine in rats. Pharmacol. Biochem. Behav. 55:1996;203-207.
13. Bhargava H.N. Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50488H, a kappa-opiate receptor agonist in the rat. Gen. Pharmacol. 26:1995;1055-1060.
14. Bhargava H.N. Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. Gen. Pharmacol. 28:1997;61-64.
15. 3H ]MK-801 to brain regions and spinal cord of rats treated chronically with U-50488H, a kappa-opioid receptor agonist Brain Res. 749:1997;347-350.
16. Bhargava H.N., Matwyshyn G.A., Gudehithlu K.P. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50488H and brain and spinal cord kappa-opioid receptors in the rat. Pharmacology. 51:1995;323-330.
17. Bhargava H.N., Thorat S.N. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50488H, a kappa-opioid receptor agonist, in the mouse. Brain Res. 649:1994;111-116.
18. Bhargava H.N., Thorat S.N. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats. Brain Res. 747:1997;246-251.
19. Bhargava H.N., Zhao G.M. Effects of N-methyl-D-aspartate receptor antagonists on the analgesia and tolerance to D-Ala2, Glu4 deltorphin II, a delta 2-opioid receptor agonist in mice. Brain Res. 719:1996;56-61.
20. 2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J. Pharmacol. Exp. Ther. 277:1996;484-490.
21. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., Porreca F. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain. 68:1996;229-237.
22. Bonnot A., Corio M., Tramu G., Viala D. Immunocytochemical distribution of ionotropic glutamate receptor subunits in the spinal cord of the rabbit. J. Chem. Neuroanat. 11:1996;267-278.
23. Brauneis U., Oz M., Peoples R.W., Weight F.F., Zhang L. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subunits to inhibition by dynorphin. J. Pharmacol. Exp. Ther. 279:1996;1063-1068.
24. Bredt D., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
25. Brennan T.J., Umali E.F., Zahn P.K. Comparison of pre- versus post-incision administration of intrathecal bupivacaine and intrathecal morphine in a rat model of postoperative pain. Anesthesiology. 87:1998;1517-1528.
26. Brodsky M., Elliott K., Hynansky A., Jenab S., Inturrisi C.E. Quantitation of mu-opioid receptor (MOR-1) mRNA in selected regions of the rat CNS. NeuroReport. 6:1995;725-729.
27. Caudle R.M., Chavkin C., Dubner R. Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J. Neurosci. 14:1994;5580-5589.
28. Chapman V., Haley J.E., Dickenson A.H. Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anesthesiology. 81:1994;1429-1435.
29. Chen L., Gu Y., Huang L.Y. The mechanism of action for the block of NMDA receptor channels by the opioid peptide, dynorphin. J. Neurosci. 15:1995;4602-4611.
30. Chen L., Gu Y., Huang L.Y.M. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. 482:1995;575-581.
31. Chen L., Huang L.Y.M. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ-opioids. Neuron. 7:1991;319-326.
32. Chen Z.R., Irvine R.J., Somogyi A.A., Bochner F. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci. 48:1991;2165-2171.
33. Cheng P.Y., Svingos A.L., Wang H., Clarke C.L., Jenab S., Beczkowska I.W., Inturrisi C.E., Pickel V.M. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J. Neurosci. 15:1995;5976-5988.
34. Delfs J.M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., Chesselet M.F. Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 345:1994;46-68.
35. DePaoli A.M., Hurley K.M., Yasada K., Reisine T., Bell G. Distribution of kappa-opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study. Mol. Cell Neurosci. 5:1994;327-335.
36. Ding Y.Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J. Comp. Neurol. 367:1996;375-402.
37. Dohrn C.S., Beitz A.J. Differential NMDA NR1 mRNA expression among spinal trigeminal neurons that project to different targets. NeuroReport. 5:1994;1857-1860.
38. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
39. 3H ]CGP-39653 binding to rat brain membranes Eur. J. Pharmacol. 271:1994;241-244.
40. Dunah A.W., Yasuda R.P., Wang Y.H., Luo J., Davila-Garcia M., Gbadegesin M., Vicini S., Wolfe B.B. Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J. Neurochem. 67:1996;2335-2345.
41. Ebert B., Andersen S., Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci. Lett. 187:1995;165-168.
42. Elliott K., Hynansky A., Inturrisi C.E. Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain. 59:1994;361-368.
43. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain. 56:1994;69-75.
44. Emmerson P.J., Liu M.R., Woods J.H., Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271:1994;1630-1637.
45. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220.
46. George S.R., Zastawny R.L., Briones-Urbina R., Cheng R., Nguyen T., Heiber M., Kouvelas A., Chan A.S., O'Dowd B.F. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun. 205:1994;1438-1444.
47. Gies E.K., Peters D.M., Gelb C.R., Knag K.M., Peterfreund R.A. Regulation of mu opioid receptor mRNA levels by activation of protein kinase C in human SH-SY5Y neuroblastoma cells. Anesthesiology. 87:1998;1127-1138.
48. Gorman A.L., Elliott K.J., Inturrisi C.E. The D- and L-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223:1997;5-8.
49. Gracy K.N., Pickel V.M. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res. 747:1997;259-272.
50. Gracy K.N., Svingos A.L., Pickel V.M. Dual ultrastructural localization of mu-opioid receptors and NMDA-type glutamate receptors in the shell of the rat nucleus accumbens. J. Neurosci. 17:1997;4839-4848.
51. Grisel J.E., Watkins L.R., Maier S.F. Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord. Psychopharmacology (Berlin). 128:1996;248-255.
52. Hiller J.M., Zhang Y., Bing G., Gioannini T.L., Stone E.A., Simon E.J. Immunohistochemical localization of mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein. Neuroscience. 62:1994;829-841.
53. Ho J., Mannes A.J., Dubner R., Caudle R.M. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. J. Pharmacol. Exp. Ther. 281:1997;136-141.
54. Hoffmann O., Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats. NeuroReport. 7:1996;838-840.
55. Honda C.N., Arvidsson U. Immunohistochemical localization of delta- and mu-opioid receptors in primate spinal cord. NeuroReport. 6:1995;1025-1028.
56. Hunter J.C., Atwal P., Woodruff G.N., Singh L. Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine. Br. J. Pharmacol. 112:1994;1002-1003.
57. Ibuki T., Dunbar S.A., Yaksh T.L. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain. 70:1997;125-132.
58. Jeziorski M., White F.J., Wolf M.E. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse. 16:1994;137-147.
59. Jhamandas K.H., Marsala M., Ibuki T., Yaksh T.L. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J. Neurosci. 16:1996;2758-2766.
60. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenin-induced inflammation. J. Neurosci. 15:1995;8156-8166.
61. Kalb R.G., Fox A.J. Synchronized overproduction of AMPA, kainate, and NMDA glutamate receptors during human spinal cord development. J. Comp. Neurol. 384:1997;200-210.
62. Katz J., Clairoux M., Redahan C., Kavanagh B.P., Carroll S., Nierenberg H., Jackson M., Beattie J., Taddio A., Sandler A.N. High-dose alfentanil pre-empts pain after abdominal hysterectomy. Pain. 68:1996;109-118.
63. Keniston L., Mao J., Price D.D., Lu J., Mayer D.J. Co-localization of μ-opioid and N-methyl-D-aspartate receptors to single neurons in the spinal cord dorsal horn of the adult rat. Soc. Neurosci. Abstr. 24:1998;390.
64. Kolesnikov Y., Jain S., Wilson R., Pasternak G.W. Blockade of morphine-induced hind limb myoclonic seizures in mice by ketamine. Pharmacol. Biochem. Behav. 56:1997;423-425.
65. Kolesnikov Y.A., Maccechini M.L., Pasternak G.W. 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci. 55:1994;1393-1398.
66. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to κ-opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5162-5166.
67. Kovoor A., Celver J., Abdryashitov R.I., Chavkin C., Gurevich V.V. Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J. Biol. Chem. 274:1999;6831-6834.
68. Kovoor A., Celver J.P., Wu A., Chavkin C. Agonist induced homologous desensitization of μ-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy. Mol. Pharmacol. 54:1998;704-711.
69. Kovoor A., Nappey V., Kieffer B.L., Chavkin C. Mu and delta opioid receptors are differentially desensitized by the co-expression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in Xenopus oocytes. J. Biol. Chem. 272:1997;27605-27611.
70. Kreeger J.S., Yukhananov R., Larson A.A. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal. Brain Res. 663:1994;101-106.
71. Kus L., Saxon D., Beitz A.J. NMDA R1 mRNA distribution in motor and thalamic-projecting sensory neurons in the rat spinal cord and brain stem. Neurosci. Lett. 196:1995;201-204.
72. Liu H., Wang H., Sheng M., Jan L.Y., Jan Y.N., Basbaum A.I. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8383-8387.
73. Lutfy K., Hurlburt D.E., Weber E. Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:1993;83-88.
74. Lutfy K., Shen K.Z., Woodward R.M., Weber E. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test. Brain Res. 731:1996;171-181.
75. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain. 67:1996;79-88.
76. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned mu-opioid receptor in the rat CNS. J. Chem. Neuroanat. 8:1995;283-305.
77. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350:1994;412-438.
78. Mansour A., Fox C.A., Meng F., Akil H., Watson S.J. Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol. Cell Neurosci. 5:1994;124-144.
79. Mao J., Price D.D., Caruso F.S., Mayer D.J. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain. 67:1996;361-368.
80. Mao J., Price D.D., Lu J., Mayer D.J. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Neurosci. Lett. 250:1998;193-196.
81. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
82. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
83. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
84. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
85. Mao J., Price D.D., Phillips L.L., Lu J., Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677:1995;257-267.
86. Marek P., Ben Eliyahu S., Gold M., Liebeskind J.C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:1991;77-81.
87. Marek P., Ben Eliyahu S., Vaccarino A.L., Liebeskind J.C. Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:1991;163-165.
88. Martin G., Nie Z., Siggins G.R. Mu-opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J. Neurosci. 17:1997;11-22.
89. Max M.B., Byas-Smith M.G., Gracely R.H., Bennett G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin. Neuropharmacol. 18:1995;360-368.
90. Mayer D.J., Mao J. Mechanisms of opioid tolerance. Pain Forum. 8:1999;14-18.
91. Mayer D.J., Mao J., Holt J., Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance and their interactions. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7731-7736.
92. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
93. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu-opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
94. Mignat C., Wille U., Ziegler A. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes. Life Sci. 56:1995;793-799.
95. 3H ]-CGP 39653 in rat brain Br. J. Pharmacol. 119:1996;819-828.
96. Narita M., Feng Y., Makimura M., Hoskins B., Ho I.K. A protein kinase inhibitor, H7, inhibits the development of tolerance to opioid antinociception. Eur. J. Pharmacol. 271:1994;543-545.
97. Narita M., Makimura M., Feng Y., Hoskins B., Ho I.K. Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650:1994;175-179.
98. Narita M., Mizoguchi H., Kampine J.P., Tseng L.F. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol. 118:1996;1829-1835.
99. Narita M., Mizoguchi H., Tseng L.F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280:1995;R1-R3.
100. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the anti-allodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain. 69:1997;317-322.
101. Nishizuka Y. The family of protein kinase C for signal transduction. JAMA. 262:1989;1826-1833.
102. Nomura K., Reuveny E., Narahashi T. Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther. 270:1994;466-474.
103. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199:1995;87-90.
104. Park K.M., Max M.B., Robinovitz E., Gracely R.H., Bennett G.J. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain. 63:1995;163-172.
105. Petralia R.S., Wang Y.X., Wenthold R.J. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J. Neurosci. 14:1994;6102-6120.
106. Petralia R.S., Yokotani N., Wenthold R.J. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14:1994;667-696.
107. Popik P., Skolnick P. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol. Biochem. Behav. 53:1996;791-797.
108. Randic M., Cheng G., Kojic L. Kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J. Neurosci. 15:1995;6809-6826.
109. Raynor K., Kong H., Mestek A., Bye L.S., Tian M., Liu J., Yu L., Reisine T. Characterization of the cloned human mu-opioid receptor. J. Pharmacol. Exp. Ther. 272:1995;423-428.
110. 3H ]dextrorphan binding sites in rat brain determined by quantitative autoradiography J. Pharmacol. Exp. Ther. 277:1996;1823-1836.
111. Saucier D.M., Kavaliers M. Antagonistic effects of the selective, competitive N-methyl-D-aspartate (NMDA) receptor antagonist, NPC-12626, on kappa opiate-induced analgesia in male deer mice. Brain Res. 637:1994;292-296.
112. Schafer M.K., Bette M., Romeo H., Schwaeble W., Weihe E. Localization of kappa-opioid receptor mRNA in neuronal subpopulations of rat sensory ganglia and spinal cord. Neurosci. Lett. 167:1994;137-140.
113. Siegel S.J., Brose N., Janssen W.G., Gasic G.P., Jahn R., Heinemann S.F., Morrison J.H. Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. U.S.A. 91:1994;564-568.
114. Simonin F., Befort K., Gaveriaux-Ruff C., Matthes H., Nappey V., Lannes B., Micheletti G., Kieffer B. The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol. Pharmacol. 46:1994;1015-1021.
115. Simonin F., Gaveriaux-Ruff C., Befort K., Matthes H., Lannes B., Micheletti G., Mattei M.G., Charron G., Bloch B., Kieffer B. Kappa-opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7006-7010.
116. Sivilotti L.G., Gerber G., Rawat B., Woolf C.J. Morphine selectively depresses the slowest, NMDA-independent component of C-fiber-evoked synaptic activity in the rat spinal cord in vitro. Eur. J. Neurosci. 7:1995;12-18.
117. Sorkin L.S., Puig S. Neuronal model of tactile allodynia produced by spinal strychnine: effects of excitatory amino acid receptor antagonists and a mu-opiate receptor agonist. Pain. 68:1996;283-292.
118. Suh H.W., Song D.K., Kim Y.H., Yoo J.S., Tseng L.F. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice. Eur. J. Pharmacol. 263:1994;217-221.
119. 3H ]3-OH-PCP binding sites in rat brain Eur. J. Pharmacol. 310:1996;243-255.
120. Tal M., Bennett G.J. Neuropathic pain sensations are differentially sensitive to dextrorphan. NeuroReport. 5:1994;1438-1440.
121. Tanganelli S., Antonelli T., Morari M., Bianchi C., Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:1991;270-272.
122. P.K. Thomas, Clinical features and differential diagnosis of peripheral neuropathy, in: P.J. Dyck, P.K. Thomas, E.H. Lambert, R. Bunge (Eds.), Peripheral Neuropathy, W.B. Saunders, Philadelphia, 1984, pp. 1169-1190.
123. S.W.N. Thompson, C.J. Woolf, Primary afferent-evoked prolonged potentials in the spinal cord and their central summation: role of the NMDA receptor, in: M.R. Bond, J.E. Carlton, C.J. Woolf (Eds.), Proceedings of the VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 291-298.
124. Tiseo P.J., Cheng J., Pasternak G.W., Inturrisi C.E. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268:1994;195-201.
125. Tiseo P.J., Inturrisi C.E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264:1993;1090-1096.
126. Tokuyama S., Wakabayashi H., Ho I.K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295:1996;123-129.
127. Tolle T.R., Berthele A., Laurie D.J., Seeburg P.H., Zieglgansberger W. Cellular and subcellular distribution of NMDAR1 splice variant mRNA in the rat lumbar spinal cord. Eur. J. Neurosci. 7:1995;1235-1244.
128. Trujillo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist, MK-801. Science. 251:1991;85-87.
129. Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., Malan T.P. Jr., Porreca F. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain. 68:1996;275-281.
130. Vaughan C.W., Christie M.J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (London). 498:1997;463-472.
131. Vigano A., Fan D., Bruera E. Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain. 67:1996;115-119.
132. 2+ uptake and glutamate release in rat cerebral cortex in primary culture J. Neurochem. 68:1997;517-524.
133. Watanabe M., Mishina M., Inoue Y. Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J. Comp. Neurol. 345:1994;314-319.
134. G. Wilcox, Excitatory neurotransmitters and pain, in: M.R. Bond, J.E. Charlton, C.J. Woolf (Eds.), Proceedings of the VIth World Congress on Pain, Elsevier, New York, 1991, pp. 97-114.
135. 2+ channels. J. Neurosci. 15:1995;4124-4132.
136. Wong C.S., Cherng C.H., Luk H.N., Ho S.T., Tung C.S. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Eur. J. Pharmacol. 297:1996;27-33.
137. Zhang C., Wong-Riley M.T. Do nitric oxide synthase, NMDA receptor subunit R1 and cytochrome oxidase co-localize in the rat central nervous system? Brain Res. 729:1996;205-215.
138. Zhang K.M., Wang X.M., Mokha S.S. Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis). Brain Res. 719:1996;229-233.
139. Zhao G.M., Bhargava H.N. Effect of antagonism of the NMDA receptor on tolerance to [D-Pen2,D-Pen5]enkephalin, a delta 1-opioid receptor agonist. Peptides. 17:1996;233-236.